<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2025.1659729</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Characterization and immunoprotection of thioredoxin reductase TrxB knockout mutant of <italic>Salmonella</italic> Enteritidis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhu</surname>
<given-names>Siping</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2784084/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Lili</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Hong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Chihuan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhu</surname>
<given-names>Xintong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ren</surname>
<given-names>Chao</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Xiaochen</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dong</surname>
<given-names>Yulai</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shi</surname>
<given-names>Qiumei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhang</surname>
<given-names>Zhiqiang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2950993/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Hebei key laboratory of preventive veterinary medicine, Hebei Normal University of Science &amp; Technology</institution>, <addr-line>Qinhuangdao</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Weichang Man and Mongolian Autonomous County Xinrui Agricultural Development Ltd.</institution>, <addr-line>Chengde</addr-line>,&#xa0;<country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Sara Mar&#xed;a Soto, Instituto Salud Global Barcelona (ISGlobal), Spain</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/466148/overview">Pengpeng Xia</ext-link>, Yangzhou University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1465068/overview">Mauro Saraiva</ext-link>, S&#xe3;o Paulo State University, Brazil</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1701081/overview">Shenye Yu</ext-link>, Chinese Academy of Agricultural Sciences (CAAS), China</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Zhiqiang Zhang, <email xlink:href="mailto:zhangzhiqiang87@hevttc.edu.cn">zhangzhiqiang87@hevttc.edu.cn</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work and share first authorship</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>17</day>
<month>09</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>15</volume>
<elocation-id>1659729</elocation-id>
<history>
<date date-type="received">
<day>04</day>
<month>07</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>01</day>
<month>09</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Zhu, Wang, Li, Li, Zhu, Ren, Liu, Dong, Shi and Zhang.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Zhu, Wang, Li, Li, Zhu, Ren, Liu, Dong, Shi and Zhang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>
<italic>Salmonella</italic> Enteritidis (<italic>S</italic>. Enteritidis) is an important zoonotic pathogen that poses a major threat to animals and human health. TrxB, as a key component of the thioredoxin system, is a thioredoxin reductase ubiquitously present in organisms. It is mainly involved in maintaining cellular redox balance, but its role in the pathogenicity of <italic>S</italic>. Enteritidis remains unclear.</p>
</sec>
<sec>
<title>Methods</title>
<p>In this study, we generated a <italic>trxB</italic>-deficient strain from <italic>S</italic>. Enteritidis C50336 strain to investigate how TrxB affects the biological characteristics and pathogenesis of the bacterium. The virulence of &#x394;<italic>trxB</italic> was assessed by measuring &#x394;<italic>trxB</italic> resistance to environmental stress, biofilm formation ability, motility, adhesion, invasion ability, intracellular survival, LD<sub>50</sub>, virulence gene expression levels, and <italic>in vivo</italic> colonization ability. Additionally, the study measured specific IgG antibody levels in mice, lymphocyte proliferation, and the immunoprotective effect of &#x394;<italic>trxB</italic>.</p>
</sec>
<sec>
<title>Results</title>
<p>We found that deletion of <italic>trxB</italic> gene did not affect the growth and biochemical properties of the <italic>S</italic>. Enteritidis strain but significantly reduced its motility, drug resistance, biofilm formation, and tolerance to environmental stress. After <italic>trxB</italic> knocked out, the adhesion and invasion capacities of <italic>S</italic>. Enteritidis to Caco-2 cells, along with its proliferation in RAW264.7 cells, were significantly reduced. Additionally, the <italic>trxB</italic>-deficient strain exhibited significantly lower pathogenicity than the parental strain, evidenced by a more than 100-fold increase in LD<sub>50</sub>. We also observed a significant decrease in the expression of virulence-related genes in the <italic>trxB</italic>-knockout mutant. More importantly, immunization with this deletion strain can confer promising protection against challenge with the C50336 strain.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>These findings indicate that TrxB is a crucial virulence factor in <italic>S</italic>. Enteritidis, playing critical roles in its pathogenicity.</p>
</sec>
</abstract>
<kwd-group>
<kwd>
<italic>Salmonella</italic> Enteritidis</kwd>
<kwd>TrxB</kwd>
<kwd>gene deletion</kwd>
<kwd>virulence</kwd>
<kwd>vaccine</kwd>
</kwd-group>
<counts>
<fig-count count="8"/>
<table-count count="4"/>
<equation-count count="0"/>
<ref-count count="35"/>
<page-count count="14"/>
<word-count count="6683"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Molecular Bacterial Pathogenesis</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>
<italic>S</italic>. Enteritidis, a common zoonotic pathogen, can cause gastroenteritis and systemic infections in humans and various animals. These infections result in high morbidity and harm, posing a significant threat to livestock production and human health (<xref ref-type="bibr" rid="B15">Knodler and Elfenbein, 2019</xref>). <italic>S</italic>. Enteritidis is mainly transmitted via the fecal-oral route. During infection, various environmental stresses and host immune responses may affect its infectivity. Over time, <italic>S</italic>. Enteritidis has evolved to evade host defenses by expressing various virulence factors that aid its adaptation and replication within the host (<xref ref-type="bibr" rid="B8">Coburn et&#xa0;al., 2007</xref>; <xref ref-type="bibr" rid="B27">Quan et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B33">Takaya et&#xa0;al., 2019</xref>).</p>
<p>The thioredoxin system (Trx) is a widespread antioxidant enzyme system found in all living organisms. It plays a crucial role in maintaining cellular redox balance and facilitating redox-mediated signal transduction (<xref ref-type="bibr" rid="B12">Kanzok et&#xa0;al., 2001</xref>; <xref ref-type="bibr" rid="B3">Branco et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B21">Lu and Holmgren, 2014a</xref>; <xref ref-type="bibr" rid="B28">Ren et&#xa0;al., 2018</xref>). Additionally, the Trx system was also reported to be a thiol- and protein-repair system, protecting organisms from protein inactivation caused by cysteine residue oxidation under oxidative conditions (<xref ref-type="bibr" rid="B18">Kreimer et&#xa0;al., 1997</xref>). In tumor research, TrxB has been demonstrated to be an effective cancer therapy target due to its critical role in maintaining cellular redox homeostasis and redox-mediated signal transduction. In bacteria, TrxB has been reported to be involved in removing reactive oxygen species in cells, thereby benefiting bacterial survival under oxidative stress conditions (<xref ref-type="bibr" rid="B19">Kuhns et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B6">Chupakhin and Krasavin, 2021</xref>). As a typical intracellular pathogen, <italic>Salmonella</italic> encounters various stressors, including reactive oxygen species (ROS) and reactive nitrogen species (RNS), in macrophages and epithelial cells during infection (<xref ref-type="bibr" rid="B16">Kobayashi, 2019</xref>). In a recent study, oxidative stress was also reported to stimulate the transcription of <italic>Salmonella</italic> pathogenicity island-2 (<italic>SPI</italic>-2) genes, thereby affecting its replication within macrophages (<xref ref-type="bibr" rid="B14">Kim et&#xa0;al., 2022</xref>). Therefore, we hypothesized that TrxB plays a significant role in the pathogenicity of <italic>S</italic>. Enteritidis. In the present study, we generated a Trx-inactivated strain of <italic>S</italic>. Enteritidis by knocking out the core enzyme TrxB and assessed the effect of this protein on the pathogenicity of <italic>S</italic>. Enteritidis through comparative analysis of virulence-related biological properties.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Bacterial strains, cells and plasmids</title>
<p>
<italic>S</italic>. Enteritidis C50336 was isolated from the feces of a patient with diarrhea and purchased from the National Institute for the Control of Pharmaceutical and Biological Products (China). It was kept in the Key Laboratory of Preventive Veterinary Medicine, Hebei Province. Unless otherwise stated, the strains used in this study were cultured in Luria broth (LB) liquid medium(Haibo Biotechnology Co., Ltd., HB0128, China) (37 &#xb0;C, 180 r/min). The cells used in this study, Caco-2BBE cells and RAW264.7 cells, were both maintained in the Key Laboratory of Preventive Veterinary Medicine of Hebei Province. They were cultured in a CO<sub>2</sub> incubator with 5% CO<sub>2</sub> using high-sucrose Dulbecco&#x2019;s Modified Eagle Medium (DMEM) (Thermo Fisher Scientific Co., Ltd., USA) supplemented with 10% fetal bovine serum (Thermo Fisher Scientific Co., Ltd., China) and 1% Penicillin-Streptomycin Solution (Beijing Solarbio Science &amp; Technology Co., Ltd., China). Gentamicin (100 &#x3bc;g/mL) was added to the medium when necessary. The plasmids pKD3, pKD46, pBR322 and pCP20 for bacterial gene knockout were provided by Invitrogen.</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Experimental animals</title>
<p>Kunming mice (6&#x2013;8 weeks old) were purchased from Beijing Speifu Biotechnology Co., Ltd. (Beijing, China) and kept according to standard protocols for animal experiments.</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Construction of a <italic>trxB</italic> gene deletion strain and a complementary strain of <italic>S. Enteritidis</italic>
</title>
<p>The <italic>trxB</italic> gene-deleted strain was constructed using the &#x3bb;-Red homologous recombination technique. The plasmid pKD3 served as a template to amplify the <italic>cat</italic> targeting gene fragment using P1/P2 primers (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>). This fragment was then electrotransformed into C50336-pKD46 receptor cells. The strain was identified by PCR using P3/P4 primers (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>). Subsequently, the strain was incubated in a water bath at 42&#xb0;C for 5 to 6 hours to eliminate pKD46. Finally, the deletion strain C50336&#x394;<italic>trxB</italic>::<italic>cat</italic> containing the <italic>cat</italic> gene was obtained. The extracted genome of the C50336 strain was used as a template to amplify the <italic>trxB</italic> gene fragment by PCR using P5/P6 primers (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>). This fragment was cloned into the pBR322 plasmid to construct the recombinant plasmid pBR322-<italic>trxB</italic>. After sequencing confirmed the correct plasmid, it was electrotransformed into the &#x394;<italic>trxB</italic> strain. The complementary strain, named &#x394;<italic>trxB</italic>+<italic>trxB</italic>, was then constructed and verified by PCR and sequencing using P3/P4 primers. The purified PCR product was sent to Sangon Biotech (Shanghai) Co., Ltd. (China) for sequencing. The <italic>trxB</italic> gene expression in &#x394;<italic>trxB</italic> and &#x394;<italic>trxB</italic>+<italic>trxB</italic> was confirmed by qPCR. Briefly, RNA of each strain was extracted using a bacterial RNA extraction kit (Beijing Aidlab Biotechnologies Co., Ltd., RN63, China), reverse transcribed into cDNA, and subjected to qPCR verification using primers P7 and P8 (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>) to assess the expression of the <italic>trxB</italic> gene.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Primers used for constructing the mutant and the complemented strain.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Primer</th>
<th valign="middle" align="left">Sequence (5&#x2019;-3&#x2019;)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">P1</td>
<td valign="middle" align="left">CTCATGGGCACGACCAAACACAGTAAGCTGCTTATTCTGGGCTCAGGACCGTGTAGGCTGGAGCTGCTTCG</td>
</tr>
<tr>
<td valign="middle" align="left">P2</td>
<td valign="middle" align="left">AAAGTCCGGCGATGTCCAGCGTCTCGATATTATCGCTCTGCTGCGTGTCGATGGGAATTAGCCATGGTCC</td>
</tr>
<tr>
<td valign="middle" align="left">P3</td>
<td valign="middle" align="left">TATGTCCGCAGTTACGTTGGC</td>
</tr>
<tr>
<td valign="middle" align="left">P4</td>
<td valign="middle" align="left">CAGGATACCTCTTACACCCTCACC</td>
</tr>
<tr>
<td valign="middle" align="left">P5</td>
<td valign="middle" align="left">CG<underline>GGATCC</underline> ATGGGCACGACCAAACACAGTAAGC</td>
</tr>
<tr>
<td valign="middle" align="left">P6</td>
<td valign="middle" align="left">GC<underline>GTCGAC</underline>CTATTTGCTCGCGTCGGCCAGA</td>
</tr>
<tr>
<td valign="middle" align="left">P7</td>
<td valign="middle" align="left">CGATAGACCGAAACCCAGAG</td>
</tr>
<tr>
<td valign="middle" align="left">P8</td>
<td valign="middle" align="left">GCGGAGGACAAAGACCAGTA</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Growth curve analysis</title>
<p>The strains were cultured overnight, and then transferred into LB and M9 medium with a 1:50 dilution on the next day, and cultured at 37&#xb0;C with shaking at 180 rpm. M9 medium consists of 17 g Na<sub>2</sub>HPO<sub>4</sub>&#xb7;7H<sub>2</sub>O, 3 g KH<sub>2</sub>PO<sub>4</sub>, 0.5 g NaCl and 1.0 g NH<sub>4</sub>Cl. The OD<sub>600</sub> was measured every hour for 10 hours by sampling the culture. Finally, the growth curve was plotted to analyze the strains&#x2019;s growth characteristics.</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>Bacterial motility assay</title>
<p>Bacterial motility was analyzed on semi-solid plates following the method described in literature (<xref ref-type="bibr" rid="B10">Duan et&#xa0;al., 2012</xref>). Five microliters of overnight culture was punctured into the center of the semi-solid medium plate and incubated at 37 &#xb0;C for 5 h. The bacterial motility was assessed by measuring the diameter of growth on the semi-solid medium plate.</p>
</sec>
<sec id="s2_6">
<label>2.6</label>
<title>Detection of biofilm formation</title>
<p>Referring to the literature (<xref ref-type="bibr" rid="B9">Dong et&#xa0;al., 2011</xref>), bacterial biofilms were measured using crystal violet staining for both observation and quantitative analysis. Each strain was inoculated into 5 mL of liquid medium and incubated at 30 &#xb0;C for 3 days. The bacterial cultures were removed, and the biofilms attached to the tubes were washed three times with PBS. Then, they were stained with 2% crystal violet solution for 15 minutes. The crystal violet bound to the biofilm was dissolved in anhydrous methanol to determine OD<sub>570</sub> nm values for quantifying biofilm formation. This experiment was repeated three times independently.</p>
<p>Each strain was inoculated onto medium containing Congo red (160 mg/L) and Caulmers Brilliant Blue (10 mg/L), then incubated at 28&#xb0;C for 48 hours. The morphology and color of the colonies of each strain were observed. Additionally, each strain was inoculated onto medium containing 200 mg/L fluorescent whitening agent and incubated at 28&#xb0;C for 48 hours. The fluorescence intensity of the colonies was compared under D366 nm ultraviolet light to that of the fluorescent whitening agent alone, in order to analyze cellulose production in the biofilm.</p>
</sec>
<sec id="s2_7">
<label>2.7</label>
<title>Determination of minimum inhibitory concentration of various antimicrobials</title>
<p>The minimum inhibitory concentration was determined following the Clinical and Laboratory Standards Institute guidelines (<xref ref-type="bibr" rid="B7">Clinical and Laboratory Standards Institute, 2009</xref>). The studies on the relevance of Trx system and antibiotic resistance are very limited, thus the choice of antibiotics in this study was random. In this study, 12 antimicrobials commonly used in clinical practice, including penicillin, acetylmethquine, cefotaxime, cefuroxime, ampicillin, cotrimoxazole, norfloxacin, ciprofloxacin, enrofloxacin, ofloxacin, lincomycin, and fosfomycin (Shanghai Yuanye Bio-technology Co., Ltd., China), were selected to perform the MIC test. Each overnight culture was adjusted to the same concentration (1&#xd7;10<sup>6</sup> CFU/mL). Each antimicrobial was serially two-fold diluted in test tubes containing sterile Mueller Hinton (MH) medium. Then, equal amounts of the adjusted bacterial solution were added to the serially diluted antimicrobials. The mixtures were incubated at 37 &#xb0;C for 16&#x2013;18 hours. <italic>E. coli</italic> ATCC25922 was used as the control strain. The experiment was repeated three times.</p>
</sec>
<sec id="s2_8">
<label>2.8</label>
<title>Stress tolerance assay</title>
<p>Bacterial stress tolerance was assessed by measuring the survival of each strain under stress conditions as previously described (<xref ref-type="bibr" rid="B4">Bringer et&#xa0;al., 2005</xref>). Briefly, bacteria in the logarithmic growth phase were exposed to different stresses, including acidic stress (pH 3.5), alkaline stress (pH 10.5), heat stress at 42 &#xb0;C, hypertonic stress (2.5 mol/L NaCl), and hypotonic stress induced by deionized water for 1 hour, as well as oxidative stress (10 mmol/L H<sub>2</sub>O<sub>2</sub>) for 10 minutes. After treatment, colonies were counted using serial dilution, and the survival rate of each strain was calculated as the ratio of colony-forming units (CFU) after stress exposure to the CFU before treatment. Three independent replicate experiments were used.</p>
</sec>
<sec id="s2_9">
<label>2.9</label>
<title>Adhesion, invasion and intracellular survival assays</title>
<p>The Caco-2BBE cells line, derived from colon adenocarcinoma, was used to assess bacterial adhesion and invasion abilities (<xref ref-type="bibr" rid="B17">Kortman et&#xa0;al., 2012</xref>). Caco-2 cells were seeded in 6-well plates, and a bacterial suspension in the logarithmic growth phase was added to the wells at a multiplicity of infection (MOI) of 100. The cells were centrifuged at 1000 rpm for 5 min and then incubated at 37 &#xb0;C for 1 h. Cells were washed three times with PBS, lysed with 1% Triton X-100, and the lysates were collected for bacteria counting. Adhesion rate = (number of adhered bacteria/number of bacteria in the inoculum per well) &#xd7; 100%.</p>
<p>For the invasion assay, the infection method was the same as that of the adhesion assay. After incubation for 1 h at 37 &#xb0;C in a 5% CO<sub>2</sub> incubator, the medium was replaced with DMEM containing gentamicin (100 &#x3bc;g/mL), and incubation continued for another hour. Then, cells were lysed by adding 1 mL of 1% Triton X-100. Invasion rate = (number of intracellular bacteria/number of bacteria in the inoculum per well) &#xd7; 100%.</p>
<p>The bacterial intracellular survival in macrophage was determined using cell line RAW264.7, a mouse macrophage cell line. Similar to the adhesion and invasion assays, RAW264.7 cells were infected with bacteria at a MOI of 100 and cells were incubated for 1h and then the medium was switched to DMEM containing gentamicin (100 &#x3bc;g/mL) to continue incubation. The cells were lysed at 3 and 23 hours post-infection (hpi), and the lysates were collected for bacterial enumeration. Bacterial survival and proliferation within macrophages were determined by calculating the ratio of bacterial counts at 23 hpi to those at 3 hpi.</p>
</sec>
<sec id="s2_10">
<label>2.10</label>
<title>Bacterial virulence evaluation</title>
<p>Fifty-five Kunming mice were randomly divided into 11 groups, with 5 mice in each group. Five groups were i.p. challenged with C50336 at concentration ranging from 2.1&#xd7;10<sup>8</sup> to 2.1&#xd7;10<sup>4</sup> CFU in 0.2 mL PBS per mouse. Another five groups were i.p. challenged with &#x394;<italic>trxB</italic> strains at concentration ranging from 1.3&#xd7;10<sup>10</sup> to 1.3&#xd7;10<sup>6</sup> CFU. The remaining group was challenged with equal volumes of sterile PBS as a control. The onsets of disease and deaths were recorded for 14 consecutive days, and the LD<sub>50</sub> was calculated according to the method of Reed and Mutch (<xref ref-type="bibr" rid="B26">Park et&#xa0;al., 2020</xref>).</p>
<p>To determine the bacterial load in the primary target organs of <italic>S</italic>. Enteritidis, livers, spleens, and lungs were collected from infected mice for quantitative bacterial analysis. Twenty mice were randomly divided into 2 groups with 10 mice in each, and the mice from the 2 groups were inoculated with <italic>S</italic>. Enteritidis wildtype strain and <italic>trxB</italic>-knockout mutant at the dose of 10<sup>6</sup> CFU per mouse respectively. At 6 h and 48 h post infection, Liver, spleen, and lung tissues were collected under sterile conditions, weighed and homogenized with 1 ml of sterile PBS. The homogenized solution was diluted in a gradient and spread on LB plates for bacterial counting.</p>
</sec>
<sec id="s2_11">
<label>2.11</label>
<title>Transcriptome analysis</title>
<p>The C50336 and &#x394;<italic>trxB</italic> strains were scraped from the LB plate into LB liquid medium and incubated with shaking until the OD<sub>600nm</sub> reached 1-2. Then, the bacteria were washed three times with sterile PBS. The bacterial precipitate was collected and immediately transferred to a liquid nitrogen tank for quick-freezing, followed by storage at -80 &#xb0;C in an ultra-low-temperature refrigerator. Finally, they were sent to Shanghai Meiji Biological Company. RNA sequencing and bioinformatic analysis was performed using a cloud platform (Shanghai Majorbio Bio-Pharm Technology Co., Ltd., China) based on the data generated by the Illumina platform. The differentially expressed genes (DEGs) were identified as those showing a fold change (&#x394;<italic>trxB</italic> vs. C50336) greater than 2 or less than 0.5, with a corrected p-value less than 0.05.</p>
</sec>
<sec id="s2_12">
<label>2.12</label>
<title>RNA extraction and quantitative real-time PCR</title>
<p>RNA was extracted using the Bacterial RNA Extraction Kit (Beijing Aide Biotechnology Co., Ltd., China). gDNA was eliminated during extraction using DNase I from the same company, and reverse transcription was performed using the Reverse Transcription Kit (Bohang Biotechnology Co., Ltd., China). RT-qPCR was performed using SYBR<sup>&#xae;</sup> PreMix Ex Taq II (TaKaRa Biotechnology (Dalian) Co., Ltd., China). Relative gene expression was determined according to the relative critical threshold (Ct) method using a Stratagene Mx3000P system (Agilent Technologies, CA). Data were normalized using the 2<sup>-&#x394;&#x394;Ct</sup> method to show the relative fold change of 12 virulence genes compared to C50336. The primers used for qPCR are listed in <xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>.</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Primers used for qPCR.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center">Primers</th>
<th valign="middle" align="center">Nucleotide sequences (5&#x2032;-3&#x2032;)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="center">
<italic>rpoS-</italic>F</td>
<td valign="middle" align="center">TTTTTCATCGGCCAGGATGT</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>rpoS-</italic>R</td>
<td valign="middle" align="center">CGCTGGGCGGTGATTC</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>csgD-</italic>F</td>
<td valign="middle" align="center">GCCTCATATTAACGGCGTG</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>csgD-</italic>R</td>
<td valign="middle" align="center">AGCGGTAATTTCCTGAGTGC</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>bcsA-</italic>R</td>
<td valign="middle" align="center">TGGAAGGGCAGAAAGTGAAT</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>bcsA-</italic>F</td>
<td valign="middle" align="center">GCCCAGCTTCAGAATATCCA</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>ompR-</italic>F</td>
<td valign="middle" align="center">TGTGCCGGATCTTCTTCCA</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>ompR-</italic>R</td>
<td valign="middle" align="center">CTCCATCGACGTCCAGATCTC</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>pipB-</italic>F</td>
<td valign="middle" align="center">GCTCCTGTTAATGATTTCGCTAAAG</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>pipB-</italic>R</td>
<td valign="middle" align="center">GCTCAGACTTAACTGACACCAAACTAA</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>hflK-</italic>F</td>
<td valign="middle" align="center">AGCGCGGCGTTGTGA</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>hflK-</italic>R</td>
<td valign="middle" align="center">TCAGACCTGGCTCTACCAGATG</td>
</tr>
<tr>
<td valign="middle" align="center">rfbHF</td>
<td valign="middle" align="center">ACGGTCGGTATTTGTCAACTCA</td>
</tr>
<tr>
<td valign="middle" align="center">rfbHR</td>
<td valign="middle" align="center">TCGCCAACCGTATTTTGCTAA</td>
</tr>
<tr>
<td valign="middle" align="center">Primers</td>
<td valign="middle" align="center">Nucleotide sequences (5&#x2032;-3&#x2032;)</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>spvB-</italic>F</td>
<td valign="middle" align="center">TGGGTGGGCAACAGCAA</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>spvB-</italic>R</td>
<td valign="middle" align="center">GCAGGATGCCGTTACTGTCA</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>flgG-</italic>F</td>
<td valign="middle" align="center">GCGCCGGACGATTGC</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>flgG-</italic>R</td>
<td valign="middle" align="center">CCGGGCTGGAAAGCATT</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>invH-</italic>F</td>
<td valign="middle" align="center">CCCTTCCTCCGTGAGCAAA</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>invH-</italic>R</td>
<td valign="middle" align="center">TGGCCAGTTGCTCTTTCTGA</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>sodC-</italic>F</td>
<td valign="middle" align="center">CACATGGATCATGAGCGCTTT</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>sodC-</italic>R</td>
<td valign="middle" align="center">CTGCGCCGCGTCTGA</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>ssaV-F</italic>
</td>
<td valign="middle" align="center">GCGCGATACGGACATATTCTG</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>ssaV-</italic>R</td>
<td valign="middle" align="center">TGGGCGCCACGTGAA</td>
</tr>
<tr>
<td valign="middle" align="center">16SF</td>
<td valign="middle" align="center">CCAGGGCTACACACGTGCTA</td>
</tr>
<tr>
<td valign="middle" align="center">16SR</td>
<td valign="middle" align="center">TCTCGCGAGGTCGCTTCT</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2_13">
<label>2.13</label>
<title>Measurement of immunoprotective efficacy</title>
<p>Thirty Kunming mice were randomly divided into two groups: an immunized group and a control group. The immunized group received orally of the &#x394;<italic>trxB</italic> strain, while the control group received the same dose of saline on days 0 and 14. Mice were received orally with &#x394;<italic>trxB</italic> at a dose of 1.3 &#xd7; 10<sup>8</sup> CFU and received a booster immunization with the same dose 14 days later.</p>
<p>Serum-specific IgG assay: Indirect ELISA was employed to assess the level of <italic>S</italic>. Enteritidis-specific antibodies in the serum of immunized mice. The C50336 strain was cultured to logarithmic growth stage, collected for lysis and centrifugation, and the supernatant proteins were encapsulated at 1 &#xb5;g per well. Blood was collected from the tail tip of three mice randomly taken from each group on days 0, 7, 14, 21 and 28 of immunization for serum isolation. The serum was subjected to an ELISA assay with a serum dilution of 1:400 and HRP labelled secondary antibody at a concentration of 1:10,000, and determined for OD<sub>450nm</sub> after color development.</p>
<p>Spleen index determination: Three mice were randomly selected and weighed on the 7th, 14th, 21st, and 28th days after immunization, and the spleens were picked up and weighed after euthanasia for calculation of the spleen index. The spleen index was calculated by dividing the spleen weight by the body weight of the mouse as a percentage.</p>
<p>Lymphocyte proliferation assay: Three immunized or non-immunized mice were euthanized 14 days after immunization. The spleens of the immunized mice were aseptically isolated and homogenized. The homogenate was then filtered through a 70 &#x3bc;m cell strainer (Beijing Labgic Technology Co., Ltd.) to obtain spleen cells. Red blood cells were lysed using a red blood cell lysis buffer (Beijing Solarbio Science &amp; Technology Co., Ltd.). The spleen lymphocytes were suspended in RPMI 1,640 Medium(Thermo Fisher Scientific Co., Ltd.) supplemented with 10% fetal bovine serum (FBS), 50 &#x3bc;g/mL penicillin, and 50 &#x3bc;g/mL streptomycin. Cell viability was assessed using the trypan blue exclusion test, and cells were counted using a haemocytometer. After cell counting, lymphocytes were seeded into 96-well tissue culture plate at 5&#xd7;10<sup>5</sup> cells each well. The lymphocytes were treated by adding bacterial supernatant antigen (7.5 &#x3bc;g/mL), ConA (2 &#x3bc;g/mL) and PBS of equal volume separately and furthered incubated at 37&#xb0;Cwith 5% CO<sub>2</sub> for 72 h. Lymphocyte proliferation was measured using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) Cell Proliferation and Cytotoxicity Assay Kit (Shanghai Beyotime Biotechnology Co., Ltd.) according to the instructions. Lymphocyte proliferation capacity was evaluated by the stimulation index (SI), calculated as: SI = (OD<sub>450</sub> of stimulation group &#x2212; OD<sub>450</sub> of medium-only group)/(OD<sub>450</sub> of unstimulated group &#x2212; OD<sub>450</sub> of medium-only group).</p>
<p>Relative protection measurement: Twenty KM mice were randomly divided into two groups, each containing 10 mice. Group A was the immunization group, and Group B was the control group. Mice in Group A were received orally with 1.3 &#xd7; 10<sup>8</sup> CFU/mouse of &#x394;<italic>trxB</italic>, followed by a booster immunization with the same dose at 14 dpi. Mice in Group B received an equal volume of PBS following the same immunization schedule. At 28 days post-immunization, mice of groups A and B were challenged with C50336 strain by i.p. injection at the dose of 2.1&#xd7;10<sup>8</sup> CFU. The morbidity and mortality of the mice were recorded for 14 days after challenge. The relative protection rate (RPS) was calculated using the formula: RPS = (the mortality of the control group &#x2212; the mortality of the immunization group)/the mortality of the control group &#xd7; 100%.</p>
</sec>
<sec id="s2_14">
<label>2.14</label>
<title>Ethics statement</title>
<p>All animal experiments were conducted in full compliance with international ethical standards and the Experimental Animal Regulation Ordinances (HPDST 2020-17) as stipulated by the Hebei Provincial Department of Science and Technology. The study protocol was reviewed and approved by the Animal Care and Use Committee of Hebei Normal University of Science and Technology.</p>
</sec>
<sec id="s2_15">
<label>2.15</label>
<title>Statistical analysis</title>
<p>The significance of the differences between C50336 and &#x394;<italic>trxB</italic> strains in terms of motility, biofilm formation ability, environmental tolerance, invasiveness, adhesion rate, intracellular survival rate, bacterial load, virulence factor detection, and immune protection ability were determined by GraphPad Prism 9.5.0 software was used, along with one-way analysis of variance (ANOVA) combined with t-tests. Data were expressed as mean &#xb1; standard error. Significant differences were denoted with an asterisk (*), where *p &lt;&#x2009;0.05, **p &lt;&#x2009;0.01, and ***p &lt;&#x2009;0.001 are considered to represent statistically significant differences in mean values.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>The <italic>trxB</italic> gene deletion does not affect the growth of <italic>S</italic>. Enteritidis</title>
<p>Using &#x3bb;-Red recombination technology, a <italic>trxB</italic> gene deletion mutant of <italic>S</italic>. Enteritidis C50336 (named &#x394;<italic>trxB</italic>) and corresponding complemented strain (named &#x394;<italic>trxB</italic>+<italic>trxB</italic>) were constructed. As shown in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>, the <italic>trxB</italic> knockout mutant and the complemented strain were confirmed by PCR. To access the influence of <italic>trxB</italic> deletion on the growth of <italic>S</italic>. Enteritidis, we examined the growth of each strain in LB medium and nutrient-poor M9 medium. The data showed (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1B, C</bold>
</xref>) that all three strains displayed similar growth curves in LB or M9 medium, demonstrating that <italic>trxB</italic> deletion does not affect the growth of <italic>S</italic>. Enteritidis.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Generation of <italic>trxB</italic> gene deletion strain and its responding complemented strain, and growth curves determination. <bold>(A)</bold> PCR verification of the <italic>trxB</italic> gene deletion strain and &#x394;<italic>trxB</italic>-complemented strain. The PCR amplification sizes of C50336 and &#x394;<italic>trxB</italic> were 1764bp and 1234bp respectively. The PCR product of &#x394;<italic>trxB</italic>+<italic>trxB</italic> showed the both band of C50336 and &#x394;<italic>trxB</italic> strain. <bold>(B)</bold> Growth curves of C50336, &#x394;<italic>trxB</italic>, and &#x394;<italic>trxB</italic>+<italic>trxB</italic> strains in LB broth. <bold>(C)</bold> Growth curves of C50336, &#x394;<italic>trxB</italic>, and &#x394;<italic>trxB</italic>+<italic>trxB</italic> strains in M9 medium.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1659729-g001.tif">
<alt-text content-type="machine-generated">A composite image showing three panels. Panel A: Gel electrophoresis image with a DNA ladder and three samples labeled M, 1, 2, and 3, showing distinct bands between one thousand and three thousand base pairs. Panel B: Line graph depicting bacterial growth in LB broth over ten hours with three lines representing C50336, &#x394;trxB, and &#x394;trxB+trxB strains. The growth is shown to peak around four OD units. Panel C: Line graph showing bacterial growth in M9 medium over ten hours with similar strains as Panel B, but peaking around 1.5 OD units.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>The <italic>trxB</italic> gene affects the motility of <italic>S</italic>. Enteritidis</title>
<p>The results of the motility skill assessment showed (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>) that the &#x394;<italic>trxB</italic> strain formed a much smaller swarming zone on semi-solid plates compared with C50336 and &#x394;<italic>trxB</italic>+<italic>trxB</italic> strains, and the motility of the strain after <italic>trxB</italic> gene restoration was restored compared to the <italic>trxB</italic> knockout strain, which was supported by the measurement of the diameters of the formed bacteria zones (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>). This result demonstrated that knockout of <italic>trxB</italic> could diminish the motility of <italic>S</italic>. Enteritidis.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Motiity analysisi of each strain. <bold>(A)</bold> Five &#xb5;L of the overnight culture of each strain was taken and inoculated by puncture at the center of the semi-solid LB plates containing 0.3% agar, and incubated at a constant temperature of 37 &#xb0;C for 5 h The motility of each strain was analyzed by measuring the motility diameter of the strain on the medium plate after stabbing it into semi-solid medium. <bold>(B)</bold> Quantitative results of bacterial motility analysis. The mean of three replications of the experiment. (***p &lt; 0.001).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1659729-g002.tif">
<alt-text content-type="machine-generated">Three petri dishes show bacterial growth for C50336, &#x394;trxB, and &#x394;trxB + trxB strains. A bar graph next to them compares migration diameters, indicating C50336 has the largest diameter, &#x394;trxB the smallest, and &#x394;trxB + trxB an intermediate size. Statistical significance is marked with asterisks.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>The <italic>trxB</italic> gene deletion affects <italic>S</italic>. Enteritidis biofilm formation</title>
<p>The biofilm formation ability of C50336, &#x394;<italic>trxB</italic>, and &#x394;<italic>trxB</italic>+<italic>trxB</italic> strains was examined, and the data showed (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>) that much less biofilm formation of &#x394;<italic>trxB</italic> strain was observed on tube surface compared to the C50336 and &#x394;<italic>trxB</italic>+<italic>trxB</italic> strains, while the biofilm formation ability of &#x394;<italic>trxB</italic>+<italic>trxB</italic> strains was restored compared to the <italic>trxB</italic> gene deletion strains via Crystal violet-staining. Quantitative results revealed that (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>) the <italic>trxB</italic> strain showed significantly lower absorbance values at OD<sub>570nm</sub>.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Biofilm formation capacity and composition analysis. <bold>(A)</bold> After three days of incubation of each strain in the medium, the biofilm attached to the test tubes was stained by 2% crystal violet solution to observe the formation of biofilm. <bold>(B)</bold> Qualitative detection of biofilm formation in 96- well microtiter plates, with absorbance measured at 570 nm (***p &lt; 0.001). <bold>(C)</bold> Each strain was inoculated with Congo red (160 mg/L Congo red, 10 mg/L Caulmers Brilliant Blue) medium and incubated at 28 &#xb0;C for 48 h The curli formation of the colonies of each strain were observed. <bold>(D)</bold> Each strain was inoculated into the medium containing fluorescent whitening agent (200 mg/L) and incubated at 28&#xb0;C for 48 h, and the fluorescence intensity of the colonies with the fluorescent agent was observed under D366nm UV light. ns, not significant.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1659729-g003.tif">
<alt-text content-type="machine-generated">A set of four panels showing biofilm formation and characteristics of strains C50336, &#x394;trxB, and &#x394;trxB+trxB. Panel A: Tubes with visible biofilm formation. Panel B: Bar chart of OD570nm values indicating biofilm density, with significant differences marked. Panel C: Images of colony morphology on agar plates. Panel D: Fluorescent images showing biofilm structure under UV light.</alt-text>
</graphic>
</fig>
<p>In order to clarify which components of the biofilm were affected by <italic>trxB</italic> knockout, all three strains were inoculated into Congo red medium and fluorescent-containing medium, respectively. As shown in <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>, the &#x394;<italic>trxB</italic> strain formed smooth, pale pink colonies on Congo red medium, while the C50336 and &#x394;<italic>trxB</italic>+<italic>trxB</italic> strain showed much darker color and more ruffled colonies, indicating that the deletion of <italic>trxB</italic> reduced curli production. The fluorescence luminescence intensity of &#x394;<italic>trxB</italic> was significantly different compared to C50336, and the fluorescence intensity of the &#x394;<italic>trxB</italic>+<italic>trxB</italic> strain was restored compared with the &#x394;<italic>trxB</italic> strain (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3D</bold>
</xref>). All these results strongly indicate that the TrxB gene can influence the formation of <italic>S</italic>. Enteritidis biofilm.</p>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>TrxB plays an important role in the drug resistance of <italic>S</italic>. Enteritidis</title>
<p>The antibiotic sensitivity of the strains was assessed by MIC determination (<xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref>). Compared with the wild-type strain, the <italic>trxB</italic> gene deletion strain showed an 8-fold increase in susceptibility to penicillin and mequindox, and a 4-fold increase to cefotaxime, cefuroxime, ampicillin, cotrimoxazole, norfloxacin, ciprofloxacin, enrofloxacin, oxfloxacin, lincomycin, and fosfomycin. These results strongly suggest that TrxB plays an important role in the drug resistance capacity of <italic>S</italic>. Enteritidis.</p>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>MIC of <italic>trxB</italic> gene deletion strain.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Drug name</th>
<th valign="middle" align="left">C50336</th>
<th valign="middle" align="left">&#x394;<italic>trxB</italic>
</th>
<th valign="middle" align="left">Fold change</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">Cefotaxime Sodium</td>
<td valign="middle" align="left">0.0625</td>
<td valign="middle" align="left">0.015625</td>
<td valign="middle" align="left">4</td>
</tr>
<tr>
<td valign="middle" align="left">Cefuroxim</td>
<td valign="middle" align="left">0.03125</td>
<td valign="middle" align="left">0.0078125</td>
<td valign="middle" align="left">4</td>
</tr>
<tr>
<td valign="middle" align="left">Penicillin</td>
<td valign="middle" align="left">8</td>
<td valign="middle" align="left">1</td>
<td valign="middle" align="left">8</td>
</tr>
<tr>
<td valign="middle" align="left">Ampicillin</td>
<td valign="middle" align="left">0.03125</td>
<td valign="middle" align="left">0.0078125</td>
<td valign="middle" align="left">4</td>
</tr>
<tr>
<td valign="middle" align="left">Paediatric Compound<break/>Sulfamethoxazole Tablets</td>
<td valign="middle" align="left">3200</td>
<td valign="middle" align="left">800</td>
<td valign="middle" align="left">4</td>
</tr>
<tr>
<td valign="middle" align="left">Norfloxacin</td>
<td valign="middle" align="left">0.03125</td>
<td valign="middle" align="left">0.0078125</td>
<td valign="middle" align="left">4</td>
</tr>
<tr>
<td valign="middle" align="left">Ciprofloxacin</td>
<td valign="middle" align="left">0.03125</td>
<td valign="middle" align="left">0.0078125</td>
<td valign="middle" align="left">4</td>
</tr>
<tr>
<td valign="middle" align="left">Enrofloxacin</td>
<td valign="middle" align="left">0.03125</td>
<td valign="middle" align="left">0.0078125</td>
<td valign="middle" align="left">4</td>
</tr>
<tr>
<td valign="middle" align="left">Ofloxacin</td>
<td valign="middle" align="left">0.0625</td>
<td valign="middle" align="left">0.015625</td>
<td valign="middle" align="left">4</td>
</tr>
<tr>
<td valign="middle" align="left">Lincomycin</td>
<td valign="middle" align="left">800</td>
<td valign="middle" align="left">200</td>
<td valign="middle" align="left">4</td>
</tr>
<tr>
<td valign="middle" align="left">Mequindox</td>
<td valign="middle" align="left">8</td>
<td valign="middle" align="left">1</td>
<td valign="middle" align="left">8</td>
</tr>
<tr>
<td valign="middle" align="left">Fosfomycin</td>
<td valign="middle" align="left">64</td>
<td valign="middle" align="left">16</td>
<td valign="middle" align="left">4</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3_5">
<label>3.5</label>
<title>TrxB regulates the stress response of <italic>S</italic>. Enteritidis under various environmental conditions</title>
<p>The environmental tolerance results showed (<xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4A&#x2013;F</bold>
</xref>) that the &#x394;t<italic>rxB</italic> strain had a significantly lower survival rate in acidic, alkaline, oxidative, thermal, hypertonic, and hypotonic stress environments compared with the C50336 strain. Furthermore, the survival rate of &#x394;<italic>trxB</italic>+<italic>trxB</italic> strain in stressful environments was restored compared to &#x394;<italic>trxB</italic> strains. These results indicates that TrxB plays a critical role in regulating the stress response of <italic>S</italic>. Enteritidis.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Bacterial stress-tolerance analysis. <bold>(A)</bold> The bacteria in logarithmic phase were transferred to acidic stress medium and the survival rate of each strain was calculated by bacterial counting after 1 hour of incubation. <bold>(B)</bold> The bacteria in logarithmic phase were transferred to alkaline stress medium and the survival rate of each strain was calculated by bacterial counting after 1 hour of incubation. <bold>(C)</bold> The bacteria in logarithmic phase were transferred to oxidative stress medium and the survival rate of each strain was calculated by bacterial counting after 10 min of incubation. <bold>(D)</bold> The bacteria in logarithmic phase were transferred to 42&#xb0;C and the survival rate of each strain was calculated by bacterial counting after 1 hour of incubation. <bold>(E)</bold> The bacteria in logarithmic phase were transferred to hypertonic stress medium and the survival rate of each strain was calculated by bacterial counting after 1 hour of incubation. <bold>(F)</bold> The bacteria in logarithmic phase were transferred to hypotonic stress medium and the survival rate of each strain was calculated by bacterial counting after 1 hour of incubation. The data represents the average of 3 replicates (ns, not significant, **p &lt; 0.01, ***p &lt; 0.001).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1659729-g004.tif">
<alt-text content-type="machine-generated">Bar graphs labeled A to F show survival rates for strains C50336, &#x2206;trrB, and &#x2206;trrB+trrB under various treatments: pH 3.5, pH 10.5, hydrogen peroxide, high temperature, sodium chloride, and deionized water. Significant differences are marked with asterisks.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_6">
<label>3.6</label>
<title>The <italic>trxB</italic> gene deletion affects the adhesion, invasion and intracellular survival of <italic>S</italic>. Enteritidis</title>
<p>Using Caco-2 and RAW264.7 cell models, we tested the adhesion, invasion and intracellular survival abilities of the &#x394;<italic>trxB</italic> mutant. The results showed (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5A, B</bold>
</xref>) that the adhesion and invasion rates of &#x394;<italic>trxB</italic> were significantly lower than those of C50336, and the survival of &#x394;<italic>trxB</italic> in cell-type macrophage of RAW264.7 lineage was significantly lower than that of C50336. The adhesion rate, invasion rate, and intracellular survival rate of the strain after <italic>trxB</italic> gene restoration were restored compared to the deletion strain. (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5C</bold>
</xref>). This indicates that TrxB affects the adhesion, invasion, and intracellular survival abilities of <italic>S</italic>. Enteritidis.</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Adhesion, invasion and intracellular survival analysis of each strain. <bold>(A)</bold> Caco-2 cells were infected with Each strain and incubated for 1 hour at 37 &#xb0;C Celsius in an incubator, followed by lysis of the cells using 1% Triton X-100, and the bacterial adhesion rate was calculated by drop plate counting. <bold>(B)</bold> The infection method for the invasion assay was the same as that for the adhesion assay. After 1 h of cell culture, the medium was replaced with DMEM medium containing gentamicin (100 &#x3bc;g/mL), and incubation was continued for 1 h 1 mL of 1% Triton X-100 was added to the lysed cells. Invasion of bacteria of each strain was calculated by drop plate counting. <bold>(C)</bold> The intracellular survival assay was performed in the same way as the invasion assay. The RAW264.7 cells were cultured in DMEM medium containing gentamicin (100 &#x3bc;g/mL) and lysed at 3 and 23 h after culture, respectively, and the intracellular viability of the bacteria was calculated by drop plate counting. The data represents the average of 3 replicates (*p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1659729-g005.tif">
<alt-text content-type="machine-generated">Bar charts comparing bacterial ratio in &#x201c;Caco-2&#x201d; cells and proliferation ratio in &#x201c;RAW246.7&#x201d; cells for different conditions: C50336, &#x394;trxB, and &#x394;trxB+trxB. Significant differences indicated by asterisks.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_7">
<label>3.7</label>
<title>Deletion of the <italic>trxB</italic> gene attenuates the virulence of <italic>S</italic>. Enteritidis</title>
<p>The pathogenicity results of the &#x394;<italic>trxB</italic> strain results show (<xref ref-type="table" rid="T4">
<bold>Table&#xa0;4</bold>
</xref>) that the LD<sub>50</sub> value of the C50336 strain is 3.98 &#xd7; 10<sup>6</sup> CFU, while that of the &#x394;<italic>trxB</italic> strain is 5.13 &#xd7; 10<sup>8</sup> CFU, representing a 129-fold increase. The results of bacterial burden <italic>in vivo</italic> showed (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6</bold>
</xref>) that at 6 h post-infection, the bacterial loads in the liver, spleen and lungs from &#x394;<italic>trxB</italic> group were similar to those of C50336 group. However, at 48 h post-infection, the &#x394;<italic>trxB</italic> group showed significantly lower bacterial load in the liver, spleen and lungs compared to the C50336 strain. The above results suggest that deleting the <italic>trxB</italic> gene reduces virulence of <italic>S</italic>. Enteritidis.</p>
<table-wrap id="T4" position="float">
<label>Table&#xa0;4</label>
<caption>
<p>LD<sub>50</sub> of C50336 and &#x394;<italic>trxB</italic> in KM mice.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center">Strain</th>
<th valign="middle" align="center">Inoculation dose (CFU/mouse)</th>
<th valign="middle" align="center">No. of deaths/total no. of mice</th>
<th valign="middle" align="center">LD<sub>50</sub> (CFU)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" rowspan="5" align="center">C50336</td>
<td valign="middle" align="center">2.1&#xd7;10<sup>8</sup>
</td>
<td valign="middle" align="center">5/5</td>
<td valign="middle" rowspan="5" align="center">3.98&#xd7;10<sup>6</sup>
</td>
</tr>
<tr>
<td valign="middle" align="center">2.1&#xd7;10<sup>7</sup>
</td>
<td valign="middle" align="center">4/5</td>
</tr>
<tr>
<td valign="middle" align="center">2.1&#xd7;10<sup>6</sup>
</td>
<td valign="middle" align="center">4/5</td>
</tr>
<tr>
<td valign="middle" align="center">2.1&#xd7;10<sup>5</sup>
</td>
<td valign="middle" align="center">0/5</td>
</tr>
<tr>
<td valign="middle" align="center">2.1&#xd7;10<sup>4</sup>
</td>
<td valign="middle" align="center">0/5</td>
</tr>
<tr>
<td valign="middle" rowspan="5" align="center">&#x394;trxB</td>
<td valign="middle" align="center">1.3&#xd7;10<sup>10</sup>
</td>
<td valign="middle" align="center">5/5</td>
<td valign="middle" rowspan="5" align="center">5.13&#xd7;10<sup>8</sup>
</td>
</tr>
<tr>
<td valign="middle" align="center">1.3&#xd7;10<sup>9</sup>
</td>
<td valign="middle" align="center">2/5</td>
</tr>
<tr>
<td valign="middle" align="center">1.3&#xd7;10<sup>8</sup>
</td>
<td valign="middle" align="center">0/5</td>
</tr>
<tr>
<td valign="middle" align="center">1.3&#xd7;10<sup>7</sup>
</td>
<td valign="middle" align="center">0/5</td>
</tr>
<tr>
<td valign="middle" align="center">1.3&#xd7;10<sup>6</sup>
</td>
<td valign="middle" align="center">0/5</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Distribution of bacteria in Kunming (KM) mice post infection. At 6 h and 48 h post-intraperitoneal injection of C50336 and &#x394;<italic>trxB</italic> into mice, the liver, spleen, and lungs were harvested and homogenized. The drop plate counting methods were used to calculate the bacterial load in tissues or organs. (**p &lt; 0.01, ***p &lt; 0.001).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1659729-g006.tif">
<alt-text content-type="machine-generated">Bar graph depicting bacterial counts in liver, spleen, and lung organs measured in log base ten colony-forming units. Four conditions are shown: C50336 at six hours, &#x394;trxB at six hours, C50336 at forty-eight hours, and &#x394;trxB at forty-eight hours. Significant differences are indicated by asterisks, with liver showing a difference between C50336 and &#x394;trxB at six hours, and spleen and lung showing differences at forty-eight hours.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_8">
<label>3.8</label>
<title>The <italic>trxB</italic> deletion leads to decreased expression of virulence genes</title>
<p>RNA-seq analysis identified 1561 differentially expressed genes (DEGs) in C50336 strain after <italic>trxB</italic> knockout, including 847 up-regulated and 714 down-regulated genes (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7A</bold>
</xref>).</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>DEGs screening by RNA-seq and virulence gene expression analysis. <bold>(A)</bold> Screening for differential genes with expression changes in sequencing libraries. <bold>(B)</bold> The expression levels of virulence genes in C50336, &#x394;<italic>trxB</italic> and &#x394;<italic>trxB</italic> +<italic>trxB</italic> were detected by using qPCR, with 16S rRNA as the housekeeping gene. The data represents the average of 3 replicates (*p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1659729-g007.tif">
<alt-text content-type="machine-generated">Panel A shows a volcano plot with data points indicating gene expression changes, with significant upregulated genes in red and downregulated genes in blue. Panel B consists of three bar graphs showing relative fold changes in gene expression for various strains, labeled C50336, &#x394;trxB, and &#x394;trxB+trxB, across different genes. Significant differences are marked with asterisks.</alt-text>
</graphic>
</fig>
<p>Among these DEGs, we selected virulence-related genes and confirmed their expression levels by PCR. The results showed (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7B</bold>
</xref>) that the expression of <italic>rpoS</italic>, <italic>csgD</italic>, <italic>bcsA</italic>, <italic>ompR</italic>, <italic>pipB</italic>, <italic>hflK</italic>, <italic>rfbH</italic>, <italic>spvB</italic>, <italic>flgG</italic>, <italic>ssrA</italic>, <italic>sodC</italic> and s<italic>saV</italic> was significantly reduced. These results suggest that deletion of the <italic>trxB</italic> gene downregulates expression of multiple virulence genes in <italic>S</italic>. Enteritidis.</p>
</sec>
<sec id="s3_9">
<label>3.9</label>
<title>Deletion of the <italic>trxB</italic> gene provides good immune protection in mice</title>
<p>The mice were immunized with &#x394;<italic>trxB</italic> and challenged with C50336 on day 28 (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8A</bold>
</xref>). After infection, their clinical signs and survival were monitored. The immune group mice remained in usual behavior and all survived the challenge. In contrast, control mice showed dishevelled hair, reduced appetite, and lethargy by day 2 post-challenge, with deaths beginning on day 3 and reaching 100% mortality by day 7 (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8B</bold>
</xref>). According to the formula for calculating immune protection rate, the RPS for &#x394;<italic>trxB</italic> was 100%. This suggests that the &#x394;<italic>trxB</italic> provides effective immunoprotection against C50336 attacks.</p>
<fig id="f8" position="float">
<label>Figure&#xa0;8</label>
<caption>
<p>Determination of immunoprotective effect of the &#x394;<italic>trxB</italic> mutant. <bold>(A)</bold> Kunming mice were immunized with &#x394;<italic>trxB</italic> for 28 days and infected with C50336 (2.1&#xd7;10<sup>8</sup>CFU) by intraperitoneal injection. Mice were observed daily for mortality. <bold>(B)</bold> Mouse survival curves. <bold>(C)</bold> KM mice were received orally with &#x394;<italic>trxB</italic>, using ELISA to determine the levels of IgG in mice at days 7, 14, 21 and 28 post-immunization. <bold>(D)</bold> Mice were weighed on days 7, 14, 21, and 28 post-immunization, and spleens were removed and weighed to calculate the spleen index. <bold>(E)</bold> Measurement of lymphocyte proliferation and transformation levels in the spleen of mice at 21 day post-immunization using the MTT assay, calculating the stimulation index (SI). (*p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1659729-g008.tif">
<alt-text content-type="machine-generated">Diagram featuring multiple panels:   A) Experimental timeline for KM mice involving vaccination and infection with C50336 bacteria.   B) Survival rate graph shows higher survival in the immune group compared to the C50336 infection group over 14 days.   C) Antibody titer graph indicates increased antibody levels in the immune group over 28 days.   D) Spleen index bar chart shows significant differences between PBS control and immune group, particularly at 7 days post-infection.   E) Stimulation index bar chart displays significant differences between PSB control and immune group across stimulation conditions.</alt-text>
</graphic>
</fig>
<p>Mouse blood serum was collected at different times after immunization for the detection of IgG antibody levels. The results showed (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8C</bold>
</xref>) that &#x394;<italic>trxB</italic> could induce antibody production on day 7 after immunization, and the antibody level was highest on day 14, indicating that <italic>trxB</italic> gene deletion induced humoral immune responses in mice, showing good immunogenicity.</p>
<p>Mouse spleens were collected at various time points after immunization to measure the splenic index. Results (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8D</bold>
</xref>) showed a significantly higher splenic index in immunized mice compared to controls, except at day 28 when no difference was observed. On day 21 post-immunization, splenocytes were collected for a lymphocyte proliferation assay. The data showed (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8E</bold>
</xref>) that the stimulation index (SI) index of the immunized group of mice was much higher than that of the unimmunized group.</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>Thioredoxin reductase catalyzes the reduction of thioredoxin. It plays critical roles in thioredoxin-mediated redox homeostasis, cellular homeostasis, and oxidative stress tolerance (<xref ref-type="bibr" rid="B22">Lu and Holmgren, 2014b</xref>). It is well established that thioredoxin reductase has the ability to modulate cell growth and apoptosis by affecting gene transcription, playing a pivotal role in the differentiation and proliferation of mammalian cells (<xref ref-type="bibr" rid="B20">Kwon et&#xa0;al., 2003</xref>). Especially, it has gained wide attention in cancer research and has been proven to be a reliable target for anticancer drugs (<xref ref-type="bibr" rid="B24">Mohammadi et&#xa0;al., 2019</xref>). However, the literature onthioredoxin reductase in bacteria is rare. In this study, we manipulated the knockout of TrxB, the thioredoxin reductase gene, in <italic>S</italic>. Enteritidis, and found that this protein is able to cause multiple phenotype changes, including stress resistance and biofilm formation. Moreover, <italic>trxB</italic> deletion resulted in a significant reduction in the virulence of <italic>S</italic>. Enteritidis. More importantly, the <italic>trxB</italic> knockout strain, when used as an immunogen, provided promising immune protection for mice against wildtype <italic>S</italic>. Enteritidis infection.</p>
<p>The thioredoxin system regulates cell growth and death in mammals through redox regulation (<xref ref-type="bibr" rid="B20">Kwon et&#xa0;al., 2003</xref>). In cancer research, this protein has been reported to be closely related to apoptosis, and excellent therapeutic results have been achieved using its inhibitors in treating tumors in some studies (<xref ref-type="bibr" rid="B30">She et&#xa0;al., 2023</xref>). However, in this study, deletion of <italic>trxB</italic> did not significantly decrease bacterial growth, indicating that this protein does not affect the growth of <italic>S</italic>. Enteritidis.</p>
<p>Thioredoxin reductase can help organisms cope with oxidative stress by alleviating oxidative damage, which has been demonstrated in a variety of cancer cells and bacteria (<xref ref-type="bibr" rid="B29">Serata et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B11">He et&#xa0;al., 2023</xref>). In addition, the protein has been reported to be involved in other stress environments such as disulphide stress and acid stress (<xref ref-type="bibr" rid="B34">Uziel et&#xa0;al., 2004</xref>; <xref ref-type="bibr" rid="B1">Birk et&#xa0;al., 2012</xref>). In the present study, we found that knocking out <italic>trxB</italic> significantly decreased <italic>S</italic>. Enteritidis resistance to oxidative, acid, alkali, and heat stresses. This suggests that TrxB contributes to the bacterium&#x2019;s tolerance to multiple environmental stresses.</p>
<p>Biofilm is an important accessory structure that helps bacteria survive harsh environments. It has also been reported to be closely associated with virulence (<xref ref-type="bibr" rid="B13">Karygianni et&#xa0;al., 2020</xref>). In a previous report, thioredoxin was reported to be a biofilm formation-associated factor in <italic>Salmonella</italic> using transposon insertion analysis (<xref ref-type="bibr" rid="B5">Chen and Wang, 2020</xref>). This finding is further supported by the data in this study, in which we found that the bacterial biofilm-forming capacity was significantly impaired after <italic>trxB</italic> deletion. Biofilms play a key role in bacterial resistance to antibiotics, so we also examined the drug resistance changes in bacteria before and after <italic>trxB</italic> deletion. We found that <italic>trxB</italic> deletion led to increased sensitivity of <italic>S</italic>. Enteritidis to multiple antibiotics, with up to 8-fold increase in sensitivity and the mechanism requires further investigation.</p>
<p>The oxidative stress tolerance is closely related to bacterial virulence, and as a key system regulating bacterial redox homeostasis, thioredoxin system&#x2019;s involvement in bacterial virulence regulation has been demonstrated in <italic>Edwardsiell</italic>a, <italic>Mycobacterium tuberculosis</italic> (<xref ref-type="bibr" rid="B25">Olson et&#xa0;al., 2013</xref>), and <italic>Acinetobacter baumannii</italic> (<xref ref-type="bibr" rid="B23">May et&#xa0;al., 2019</xref>). Thioredoxin has also been reported to intervene in the intracellular infection and virulence of <italic>Salmonella</italic> typhimurium (<xref ref-type="bibr" rid="B2">Bjur et&#xa0;al., 2006</xref>). In this study, we observed that TrxB deficiency significantly decreased virulence in <italic>S</italic>. Enteritidis. This was evidenced by a more than 50-fold increase in LD<sub>50</sub> in mice and an apparent reduction in bacterial load in the liver, spleen, and lung. These findings suggest that TrxB is an important virulence-associated factor of <italic>S</italic>. Enteritidis. Besides the role of antioxidant, thioredoxin functions as a cofactor for diverse enzymes and transcription factors, thereby exerting influence over their activity and function (<xref ref-type="bibr" rid="B35">Yang et&#xa0;al., 2024</xref>). We analyzed the transcriptomic changes before and after <italic>trxB</italic> deletion in <italic>S</italic>. Enteritidis, and found that up to 1561 genes were altered in expression, especially those associated with stress and virulence. Oxidative stress can activates transcription of multiple genes including <italic>SPI</italic> genes, and oxyR plays a key role in this process (<xref ref-type="bibr" rid="B32">Storz et&#xa0;al., 1990</xref>). In this study, we determined that TrxB knockout leads to down-regulation of 11 virulence gene, including <italic>SPI</italic> genes(<italic>spvB</italic>, <italic>pipB</italic>), biofilm related genes(<italic>csgD</italic>, <italic>bcsA</italic>, <italic>ompR</italic>). However, whether this downregulation effect is mediated by oxyR remains to be further investigated.</p>
<p>In <italic>S</italic>. Enteritidis, a wide range of virulence, metabolism and regulatory genes are employed for attenuated vaccine design (<xref ref-type="bibr" rid="B31">Siddique et&#xa0;al., 2024</xref>). In view of the marked reduced attenuation caused by <italic>trxB</italic> deletion in <italic>S</italic>. Enteritidis, we evaluated the potential of the <italic>trxB</italic>-deficient mutant as a vaccine. We found that immunization with this mutant could generate a promising immunity for mice against infection by wild type <italic>S</italic>. Enteritidis. Strong humoral immune responses and lymphocyte proliferation were also observed in immunized mice. These data suggest that TrxB is an potential target for <italic>S</italic>. Enteritidis design.</p>
</sec>
<sec id="s5" sec-type="conclusions">
<label>5</label>
<title>Conclusion</title>
<p>These studies indicate that TrxB is an important virulence factor of <italic>S</italic>. Enteritidis, and &#x394;<italic>trxB</italic> mutant exhibit strong immune protective effects in mice, making them potential targets for vaccine design.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Material</bold>
</xref>.</p>
</sec>
<sec id="s7" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The animal study was approved by The animal studies were approved by All animal experiments were conducted in full compliance with international ethical standards and the Experimental Animal Regulation Ordinances (HPDST 2020-17) as stipulated by the Hebei Provincial Department of Science and Technology. The study protocol was reviewed and approved by the Animal Care and Use Committee of Hebei Normal University of Science and Technology. The studies were conducted in accordance with the local legislation and institutional requirements. The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec id="s8" sec-type="author-contributions">
<title>Author contributions</title>
<p>SZ: Conceptualization, Data curation, Methodology, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. LW: Conceptualization, Data curation, Methodology, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. HL: Conceptualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. CL: Conceptualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. XZ: Formal Analysis, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. CR: Formal Analysis, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. XL: Formal Analysis, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. YD: Funding acquisition, Investigation, Supervision, Validation, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. QS: Funding acquisition, Investigation, Supervision, Validation, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. ZZ: Funding acquisition, Investigation, Supervision, Validation, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing.</p>
</sec>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research and/or publication of this article. This study was supported by Science and Technology Special Project for the Construction of Chengde National Innovation Demonstration Zones for Sustainable Development Agenda (202302F040), Natural Science Foundation of Hebei Province (C2024407005), Hebei Province High-level Talent Funding Program (C20231014), Special Funding Program for Basic Research of Universities from Hebei University of Science and Technology Normal College (2023JK14), Hebei Modern Agricultural Industry Technology System Beef Cattle Industry Innovation Team Disease Prevention and Control and Resistance Reduction Post (HBCT2023190201).</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We would also like to thank Guanxin Hou, Xinyi Sun, Fuqiang Guo, Yong Tao and Rui An for their help with this study.</p>
</ack>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>Authors YD was employed by Weichang Man and Mongolian Autonomous County Xinrui Agricultural Development Ltd.</p>
<p>The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec id="s12" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s13" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcimb.2025.1659729/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcimb.2025.1659729/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.pdf" id="SM1" mimetype="application/pdf"/>
<supplementary-material xlink:href="DataSheet2.pdf" id="SM2" mimetype="application/pdf"/>
<supplementary-material xlink:href="DataSheet3.pdf" id="SM3" mimetype="application/pdf"/>
<supplementary-material xlink:href="DataSheet4.pdf" id="SM4" mimetype="application/pdf"/>
<supplementary-material xlink:href="DataSheet5.pdf" id="SM5" mimetype="application/pdf"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Birk</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Wik</surname> <given-names>M. T.</given-names>
</name>
<name>
<surname>Lametsch</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Kn&#xf8;chel</surname> <given-names>S</given-names>
</name>
</person-group>. (<year>2012</year>). <article-title>Acid stress response and protein induction in <italic>Campylobacter jejuni</italic> isolates with different acid tolerance</article-title>. <source>BMC Microbiol.</source> <volume>12</volume>, <fpage>174</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1471-2180-12-174</pub-id>, PMID: <pub-id pub-id-type="pmid">22889088</pub-id></citation></ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bjur</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Eriksson-Ygberg</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Aslund</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Rhen</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Thioredoxin 1 promotes intracellular replication and virulence of <italic>Salmonella</italic> enterica serovar Typhimurium</article-title>. <source>Infect. Immun.</source> <volume>74</volume>, <fpage>5140</fpage>&#x2013;<lpage>5151</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.00449-06</pub-id>, PMID: <pub-id pub-id-type="pmid">16926406</pub-id></citation></ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Branco</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Godinho-Santos</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Gon&#xe7;alves</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Holmgren</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Carvalho</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Mitochondrial thioredoxin reductase inhibition, selenium status, and Nrf-2 activation are determinant factors modulating the toxicity of mercury compounds</article-title>. <source>Free Radic. Biol. Med.</source> <volume>73</volume>, <fpage>95</fpage>&#x2013;<lpage>105</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2014.04.030</pub-id>, PMID: <pub-id pub-id-type="pmid">24816296</pub-id></citation></ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bringer</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Barnich</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Glasser</surname> <given-names>A. L.</given-names>
</name>
<name>
<surname>Bardot</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Darfeuille-Michaud</surname> <given-names>A</given-names>
</name>
</person-group>. (<year>2005</year>). <article-title>HtrA stress protein is involved in intramacrophagic replication of adheren and invasive <italic>Escherichia coli</italic> strain lf82 isolated from a patient with crohn&#x2019;s disease</article-title>. <source>Infect. Immun.</source> <volume>73</volume>, <fpage>712</fpage>&#x2013;<lpage>721</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.73.2.712-721.2005</pub-id>, PMID: <pub-id pub-id-type="pmid">15664909</pub-id></citation></ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Genetic determinants of <italic>Salmonella</italic> enterica critical for attachment and biofilm formation</article-title>. <source>Int. J. Food Microbiol.</source> <volume>320</volume>, <fpage>108524</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2020.108524</pub-id>, PMID: <pub-id pub-id-type="pmid">32000116</pub-id></citation></ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chupakhin</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Krasavin</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Thioredoxin reductase inhibitors: updated patent review (2017-present)</article-title>. <source>Expert Opin. Ther. Pat.</source> <volume>31</volume>, <fpage>745</fpage>&#x2013;<lpage>758</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/13543776.2021.1899160</pub-id>, PMID: <pub-id pub-id-type="pmid">33666133</pub-id></citation></ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<collab>Clinical and Laboratory Standards Institute</collab>
</person-group>. (<year>2009</year>). <article-title>Performance standards for antimicrobial susceptibility testing; 19th informational supplement</article-title>. <source>CLSI document M100-S19</source>. (<publisher-loc>Wayne, PA</publisher-loc>: <publisher-name>Clinical and Laboratory Standards Institute</publisher-name>).</citation></ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coburn</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Grassl</surname> <given-names>G. A.</given-names>
</name>
<name>
<surname>Finlay</surname> <given-names>B. B.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>
<italic>Salmonella</italic>, the host and disease: a brief review</article-title>. <source>Immunol. Cell Biol.</source> <volume>85</volume>, <fpage>112</fpage>&#x2013;<lpage>118</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/sj.icb.7100007</pub-id>, PMID: <pub-id pub-id-type="pmid">17146467</pub-id></citation></ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Jiao</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Geng</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Roles of the spiA gene from <italic>Salmonella</italic> enteritidis in biofilm formation and virulence</article-title>. <source>Microbiology.</source> <volume>157</volume>, <fpage>1798</fpage>&#x2013;<lpage>1805</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1099/mic.0.046185-0</pub-id>, PMID: <pub-id pub-id-type="pmid">21415117</pub-id></citation></ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duan</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Bao</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Ruan</surname> <given-names>X.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>The flagella of F18ab <italic>Escherichia coli</italic> is a virulence factor that contributes to infection in a IPEC-J2 cell model <italic>in vitro</italic>
</article-title>. <source>Vet. Microbiol.</source> <volume>160</volume>, <fpage>132</fpage>&#x2013;<lpage>140</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.vetmic.2012.05.015</pub-id>, PMID: <pub-id pub-id-type="pmid">22658629</pub-id></citation></ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Fang</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Gu</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>Y</given-names>
</name>
</person-group>. (<year>2023</year>). <article-title>The thioredoxin system in edwardsiella piscicida contributes to oxidative stress tolerance, motility, and virulence</article-title>. <source>Microorganisms</source> <volume>11</volume> (<issue>4</issue>), <elocation-id>827</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/microorganisms11040827</pub-id>, PMID: <pub-id pub-id-type="pmid">37110252</pub-id></citation></ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kanzok</surname> <given-names>S. M.</given-names>
</name>
<name>
<surname>Fechner</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Bauer</surname> <given-names>H.</given-names>
</name>
<etal/>
</person-group>. (<year>2001</year>). <article-title>Substitution of the thioredoxin system for glutathione reductase in Drosophila melanogaster</article-title>. <source>Science</source> <volume>291</volume>, <fpage>643</fpage>&#x2013;<lpage>646</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.291.5504.643</pub-id>, PMID: <pub-id pub-id-type="pmid">11158675</pub-id></citation></ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karygianni</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Ren</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Koo</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Thurnheer</surname> <given-names>T</given-names>
</name>
</person-group>. (<year>2020</year>). <article-title>Biofilm matrixome: extracellular components in structured microbial communities</article-title>. <source>Trends Microbiol.</source> <volume>28</volume>, <fpage>668</fpage>&#x2013;<lpage>681</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tim.2020.03.016</pub-id>, PMID: <pub-id pub-id-type="pmid">32663461</pub-id></citation></ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>J. S.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Davenport</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Kant</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Morrison</surname> <given-names>T. E.</given-names>
</name>
<name>
<surname>Vazquez-Torres</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Oxidative stress activates transcription of <italic>Salmonella</italic> pathogenicity island-2 genes in macrophages</article-title>. <source>J. Biol. Chem.</source> <volume>298</volume>, <fpage>102130</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jbc.2022.102130</pub-id>, PMID: <pub-id pub-id-type="pmid">35714768</pub-id></citation></ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knodler</surname> <given-names>L. A.</given-names>
</name>
<name>
<surname>Elfenbein</surname> <given-names>J. R.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Salmonella enterica</article-title>. <source>Trends Microbiol.</source> <volume>27</volume>, <fpage>964</fpage>&#x2013;<lpage>965</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tim.2019.05.002</pub-id>, PMID: <pub-id pub-id-type="pmid">31160162</pub-id></citation></ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kobayashi</surname> <given-names>K.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Inactivation of inhibits biofilm formation by activating the disulfide stress regulator Spx in Bacillus subtilis</article-title>. <source>J. Bacteriology</source> <volume>201</volume>, <fpage>15</fpage>&#x2013;<lpage>21</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JB.00712-18</pub-id>, PMID: <pub-id pub-id-type="pmid">30718304</pub-id></citation></ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kortman</surname> <given-names>G. A. M.</given-names>
</name>
<name>
<surname>Boleij</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Swinkels</surname> <given-names>D. W.</given-names>
</name>
<name>
<surname>Tjalsma</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Ironavailability increases the pathogenic potential of <italic>Salmonella</italic> typhimurium and other enteric pathogens at the intestinal epithelial interface</article-title>. <source>PloS One</source> <volume>7</volume>, <elocation-id>e29968</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0029968</pub-id>, PMID: <pub-id pub-id-type="pmid">22272265</pub-id></citation></ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kreimer</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Sohling</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Andreesen</surname> <given-names>J. R.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Two closely linked genes encoding thioredoxin and thioredoxin reductase in <italic>Clostridium</italic> litorale</article-title>. <source>Arch. Microbiol.</source> <volume>168</volume>, <fpage>328</fpage>&#x2013;<lpage>337</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s002030050506</pub-id>, PMID: <pub-id pub-id-type="pmid">9297471</pub-id></citation></ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuhns</surname> <given-names>L. G.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Maier</surname> <given-names>R. J.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Comparative roles of the two <italic>Helicobacter pylori</italic> thioredoxins in preventing macromolecule Damage</article-title>. <source>Infection Immun.</source> <volume>83</volume>, <fpage>2935</fpage>&#x2013;<lpage>2943</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.00232-15</pub-id>, PMID: <pub-id pub-id-type="pmid">25964471</pub-id></citation></ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwon</surname> <given-names>Y. W.</given-names>
</name>
<name>
<surname>Masutani</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Nakamura</surname> <given-names>H.</given-names>
</name>
<etal/>
</person-group>. (<year>2003</year>). <article-title>Redox regulation of cell growth and cell death</article-title>. <source>Biol. Chem.</source> <volume>384</volume>, <fpage>991</fpage>&#x2013;<lpage>996</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1515/BC.2003.111</pub-id>, PMID: <pub-id pub-id-type="pmid">12956415</pub-id></citation></ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Holmgren</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2014</year>a). <article-title>The thioredoxin antioxidant system</article-title>. <source>Free Radic. Biol. Med.</source> <volume>66</volume>, <fpage>75</fpage>&#x2013;<lpage>87</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2013.07.036</pub-id>, PMID: <pub-id pub-id-type="pmid">23899494</pub-id></citation></ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Holmgren</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2014</year>b). <article-title>The thioredoxin antioxidant system</article-title>. <source>Free Radic. Biol. Med.</source> <volume>66</volume>, <fpage>75</fpage>&#x2013;<lpage>87</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2013.07.036</pub-id>, PMID: <pub-id pub-id-type="pmid">23899494</pub-id></citation></ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>May</surname> <given-names>H. C.</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>J. J.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>H.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Thioredoxin-A is a virulence factor and mediator of the type IV pilus system in <italic>Acinetobacter baumannii</italic>
</article-title>. <source>PloS One</source> <volume>14</volume>, <fpage>e218505</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0218505</pub-id>, PMID: <pub-id pub-id-type="pmid">31265467</pub-id></citation></ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohammadi</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Soltani</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Ghahremanloo</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Javid</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Hashemy</surname> <given-names>S. I</given-names>
</name>
</person-group>. (<year>2019</year>). <article-title>The thioredoxin system and cancer therapy: a review</article-title>. <source>Cancer Chemother. Pharmacol.</source> <volume>84</volume>, <fpage>925</fpage>&#x2013;<lpage>935</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00280-019-03912-4</pub-id>, PMID: <pub-id pub-id-type="pmid">31367788</pub-id></citation></ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olson</surname> <given-names>A. L.</given-names>
</name>
<name>
<surname>Neumann</surname> <given-names>T. S.</given-names>
</name>
<name>
<surname>Cai</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Sem</surname> <given-names>D. S</given-names>
</name>
</person-group>. (<year>2013</year>). <article-title>Solution structures of <italic>Mycobacterium tuberculosis</italic> thioredoxin C and models of intact thioredoxin system suggest new approaches to inhibitor and drug design</article-title>. <source>Proteins.</source> <volume>81</volume>, <fpage>675</fpage>&#x2013;<lpage>689</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/prot.24228</pub-id>, PMID: <pub-id pub-id-type="pmid">23229911</pub-id></citation></ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Jung</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Hong</surname> <given-names>S.-T.</given-names>
</name>
<name>
<surname>Yoon</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Hahn</surname> <given-names>T.-W.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>
<italic>Salmonella</italic> typhimurium lacking yjeK as a candidate live attenuated vaccine against invasive <italic>salmonella</italic> infection</article-title>. <source>Front. Immunol.</source> <volume>11</volume>, <elocation-id>1277</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2020.01277</pub-id>, PMID: <pub-id pub-id-type="pmid">32655567</pub-id></citation></ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quan</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Xia</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Meng</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Fimbriae and related receptors for <italic>Salmonella</italic> Enteritidis</article-title>. <source>Microb. Pathog.</source> <volume>126</volume>, <fpage>357</fpage>&#x2013;<lpage>362</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.micpath.2018.10.025</pub-id>, PMID: <pub-id pub-id-type="pmid">30347261</pub-id></citation></ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ren</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Zou</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Holmgren</surname> <given-names>A</given-names>
</name>
</person-group>. (<year>2018</year>). <article-title>Selenocysteine in mammalian thioredoxin reductase and application of ebselen as a therapeutic</article-title>. <source>Free Radic. Biol. Med.</source> <volume>127</volume>, <fpage>238</fpage>&#x2013;<lpage>247</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2018.05.081</pub-id>, PMID: <pub-id pub-id-type="pmid">29807162</pub-id></citation></ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Serata</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Iino</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Yasuda</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Sako</surname> <given-names>T</given-names>
</name>
</person-group>. (<year>2012</year>). <article-title>Roles of thioredoxin and thioredoxin reductase in the resistance to oxidative stress in <italic>Lactobacillus casei</italic>
</article-title>. <source>Microbiol. (Reading)</source> <volume>158</volume>, <fpage>953</fpage>&#x2013;<lpage>962</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1099/mic.0.053942-0</pub-id>, PMID: <pub-id pub-id-type="pmid">22301908</pub-id></citation></ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>She</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
</person-group>. (<year>2023</year>). <article-title>Discovery of novel organoarsenicals as robust thioredoxin reductase inhibitors for oxidative stress mediated cancer therapy</article-title>. <source>Biochem. Pharmacol.</source> <volume>218</volume>, <fpage>115908</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bcp.2023.115908</pub-id>, PMID: <pub-id pub-id-type="pmid">37931662</pub-id></citation></ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siddique</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Jia</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>B.</given-names>
</name>
<etal/>
</person-group>. (<year>2024</year>). <article-title>The Evolution of Vaccines Development across Salmonella Serovars among Animal Hosts: A Systematic Review</article-title>. <source>Vaccines (Basel)</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/vaccines12091067</pub-id>, PMID: <pub-id pub-id-type="pmid">39340097</pub-id></citation></ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Storz</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Tartaglia</surname> <given-names>L. A.</given-names>
</name>
<name>
<surname>Ames</surname> <given-names>B. N.</given-names>
</name>
</person-group> (<year>1990</year>). <article-title>Transcriptional regulator of oxidative stress-inducible genes: direct activation by oxidation</article-title>. <source>Science.</source> <volume>248</volume>, <fpage>189</fpage>&#x2013;<lpage>194</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.2183352</pub-id>, PMID: <pub-id pub-id-type="pmid">2183352</pub-id></citation></ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takaya</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Yamamoto</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Tokoyoda</surname> <given-names>K.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Humoral immunity vs. <italic>Salmonella</italic>
</article-title>. <source>Front. Immunol.</source> <volume>10</volume>, <elocation-id>3155</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2019.03155</pub-id>, PMID: <pub-id pub-id-type="pmid">32038650</pub-id></citation></ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uziel</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Borovok</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Schreiber</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Cohen</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Aharonowitz</surname> <given-names>Y</given-names>
</name>
</person-group>. (<year>2004</year>). <article-title>Transcriptional regulation of the <italic>Staphylococcus aureus</italic> thioredoxin and thioredoxin reductase genes in response to oxygen and disulfide stress</article-title>. <source>J. Bacteriol.</source> <volume>186</volume>, <fpage>326</fpage>&#x2013;<lpage>334</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JB.186.2.326-334.2004</pub-id>, PMID: <pub-id pub-id-type="pmid">14702300</pub-id></citation></ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Shen</surname> <given-names>Y. Q.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Q</given-names>
</name>
</person-group>. (<year>2024</year>). <article-title>Thioredoxin (Trx): A redox target and modulator of cellular senescence and aging-related diseases</article-title>. <source>Redox Biol.</source> <volume>70</volume>, <fpage>103032</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.redox.2024.103032</pub-id>, PMID: <pub-id pub-id-type="pmid">38232457</pub-id></citation></ref>
</ref-list>
</back>
</article>